Global Somatostatin Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Report Id

45961

Publisher Name

Global Info Research

Published Date

2/18/2019

No of Pages

137

Market Scenario

Somatostatin is one kind of hormone. It is widely distributed throughout the body, especially in the hypothalamus and pancreas. It also acts as an important regulator of endocrine and nervous system function by inhibiting the secretion of several other hormones such as growth hormone, insulin, and gastrin. Scope of the Report: Somatostatin is one of the fastest growing medical Products in recent years in China. China is also the world's most rapid expansion Market. Rapid growth numbers of general hospital form a strong Market Demand of Somatostatin, especially the demand of second class and below second class hospital. As the analogue is expanding in the market, and the price of Somatostatin not decreasing so much, Somatostatin will limited in many regions, like North America and EU. Even though the analogue and regional limited, the consumption of Somatostatin is keeping quick growth rate. The worldwide market for Somatostatin is expected to grow at a CAGR of roughly 11.5% over the next five years, will reach 370 million US$ in 2024, from 210 million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Somatostatin in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers Merck (Schweiz) AG SANOFI-AVENTIS FRANCE Lyomark Pharma GmbH ALFA WASSERMANN S.p.A. Polypeptide Laboratories, Inc SAMARTH UBPL HYBIO TianTaiShan Yangtze River Siyao Shuangcheng Hainan Zhonghe SL PHARM Wuhan Hualong Qingdao Guoda Chengdu Shengnuo Longjin Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Colombia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Type, covers 0.25 0.75 3 Market Segment by Applications, can be divided into Application I Application II The content of the study subjects, includes a total of 15 chapters: Chapter 1, to describe Somatostatin product scope, market overview, market opportunities, market driving force and market risks. Chapter 2, to profile the top manufacturers of Somatostatin, with price, sales, revenue and global market share of Somatostatin in 2017 and 2018. Chapter 3, the Somatostatin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast. Chapter 4, the Somatostatin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019. Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019. Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019. Chapter 12, Somatostatin market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024. Chapter 13, 14 and 15, to describe Somatostatin sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

Table of Contents 1 Market Overview 1.1 Somatostatin Introduction 1.2 Market Analysis by Type 1.2.1 0.25 1.2.2 0.75 1.2.3 3 1.3 Market Analysis by Applications 1.3.1 Application I 1.3.2 Application II 1.4 Market Analysis by Regions 1.4.1 North America (United States, Canada and Mexico) 1.4.1.1 United States Market States and Outlook (2014-2024) 1.4.1.2 Canada Market States and Outlook (2014-2024) 1.4.1.3 Mexico Market States and Outlook (2014-2024) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2014-2024) 1.4.2.2 France Market States and Outlook (2014-2024) 1.4.2.3 UK Market States and Outlook (2014-2024) 1.4.2.4 Russia Market States and Outlook (2014-2024) 1.4.2.5 Italy Market States and Outlook (2014-2024) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.3.1 China Market States and Outlook (2014-2024) 1.4.3.2 Japan Market States and Outlook (2014-2024) 1.4.3.3 Korea Market States and Outlook (2014-2024) 1.4.3.4 India Market States and Outlook (2014-2024) 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024) 1.4.4 South America, Middle East and Africa 1.4.4.1 Brazil Market States and Outlook (2014-2024) 1.4.4.2 Egypt Market States and Outlook (2014-2024) 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024) 1.4.4.4 South Africa Market States and Outlook (2014-2024) 1.4.4.5 Turkey Market States and Outlook (2014-2024) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Merck (Schweiz) AG 2.1.1 Business Overview 2.1.2 Somatostatin Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Merck (Schweiz) AG Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.2 SANOFI-AVENTIS FRANCE 2.2.1 Business Overview 2.2.2 Somatostatin Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 SANOFI-AVENTIS FRANCE Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.3 Lyomark Pharma GmbH 2.3.1 Business Overview 2.3.2 Somatostatin Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Lyomark Pharma GmbH Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.4 ALFA WASSERMANN S.p.A. 2.4.1 Business Overview 2.4.2 Somatostatin Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 ALFA WASSERMANN S.p.A. Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.5 Polypeptide Laboratories, Inc 2.5.1 Business Overview 2.5.2 Somatostatin Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Polypeptide Laboratories, Inc Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.6 SAMARTH 2.6.1 Business Overview 2.6.2 Somatostatin Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 SAMARTH Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.7 UBPL 2.7.1 Business Overview 2.7.2 Somatostatin Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 UBPL Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.8 HYBIO 2.8.1 Business Overview 2.8.2 Somatostatin Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 HYBIO Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.9 TianTaiShan 2.9.1 Business Overview 2.9.2 Somatostatin Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 TianTaiShan Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.10 Yangtze River 2.10.1 Business Overview 2.10.2 Somatostatin Type and Applications 2.10.2.1 Product A 2.10.2.2 Product B 2.10.3 Yangtze River Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.11 Siyao 2.11.1 Business Overview 2.11.2 Somatostatin Type and Applications 2.11.2.1 Product A 2.11.2.2 Product B 2.11.3 Siyao Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.12 Shuangcheng 2.12.1 Business Overview 2.12.2 Somatostatin Type and Applications 2.12.2.1 Product A 2.12.2.2 Product B 2.12.3 Shuangcheng Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.13 Hainan Zhonghe 2.13.1 Business Overview 2.13.2 Somatostatin Type and Applications 2.13.2.1 Product A 2.13.2.2 Product B 2.13.3 Hainan Zhonghe Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.14 SL PHARM 2.14.1 Business Overview 2.14.2 Somatostatin Type and Applications 2.14.2.1 Product A 2.14.2.2 Product B 2.14.3 SL PHARM Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.15 Wuhan Hualong 2.15.1 Business Overview 2.15.2 Somatostatin Type and Applications 2.15.2.1 Product A 2.15.2.2 Product B 2.15.3 Wuhan Hualong Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.16 Qingdao Guoda 2.16.1 Business Overview 2.16.2 Somatostatin Type and Applications 2.16.2.1 Product A 2.16.2.2 Product B 2.16.3 Qingdao Guoda Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.17 Chengdu Shengnuo 2.17.1 Business Overview 2.17.2 Somatostatin Type and Applications 2.17.2.1 Product A 2.17.2.2 Product B 2.17.3 Chengdu Shengnuo Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.18 Longjin 2.18.1 Business Overview 2.18.2 Somatostatin Type and Applications 2.18.2.1 Product A 2.18.2.2 Product B 2.18.3 Longjin Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 3 Global Somatostatin Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018) 3.1 Global Somatostatin Sales and Market Share by Manufacturer (2017-2018) 3.2 Global Somatostatin Revenue and Market Share by Manufacturer (2017-2018) 3.3 Market Concentration Rate 3.3.1 Top 3 Somatostatin Manufacturer Market Share in 2018 3.3.2 Top 6 Somatostatin Manufacturer Market Share in 2018 3.4 Market Competition Trend 4 Global Somatostatin Market Analysis by Regions 4.1 Global Somatostatin Sales, Revenue and Market Share by Regions 4.1.1 Global Somatostatin Sales and Market Share by Regions (2014-2019) 4.1.2 Global Somatostatin Revenue and Market Share by Regions (2014-2019) 4.2 North America Somatostatin Sales and Growth Rate (2014-2019) 4.3 Europe Somatostatin Sales and Growth Rate (2014-2019) 4.4 Asia-Pacific Somatostatin Sales and Growth Rate (2014-2019) 4.5 South America Somatostatin Sales and Growth Rate (2014-2019) 4.6 Middle East and Africa Somatostatin Sales and Growth Rate (2014-2019) 5 North America Somatostatin by Country 5.1 North America Somatostatin Sales, Revenue and Market Share by Country 5.1.1 North America Somatostatin Sales and Market Share by Country (2014-2019) 5.1.2 North America Somatostatin Revenue and Market Share by Country (2014-2019) 5.2 United States Somatostatin Sales and Growth Rate (2014-2019) 5.3 Canada Somatostatin Sales and Growth Rate (2014-2019) 5.4 Mexico Somatostatin Sales and Growth Rate (2014-2019) 6 Europe Somatostatin by Country 6.1 Europe Somatostatin Sales, Revenue and Market Share by Country 6.1.1 Europe Somatostatin Sales and Market Share by Country (2014-2019) 6.1.2 Europe Somatostatin Revenue and Market Share by Country (2014-2019) 6.2 Germany Somatostatin Sales and Growth Rate (2014-2019) 6.3 UK Somatostatin Sales and Growth Rate (2014-2019) 6.4 France Somatostatin Sales and Growth Rate (2014-2019) 6.5 Russia Somatostatin Sales and Growth Rate (2014-2019) 6.6 Italy Somatostatin Sales and Growth Rate (2014-2019) 7 Asia-Pacific Somatostatin by Country 7.1 Asia-Pacific Somatostatin Sales, Revenue and Market Share by Country 7.1.1 Asia-Pacific Somatostatin Sales and Market Share by Country (2014-2019) 7.1.2 Asia-Pacific Somatostatin Revenue and Market Share by Country (2014-2019) 7.2 China Somatostatin Sales and Growth Rate (2014-2019) 7.3 Japan Somatostatin Sales and Growth Rate (2014-2019) 7.4 Korea Somatostatin Sales and Growth Rate (2014-2019) 7.5 India Somatostatin Sales and Growth Rate (2014-2019) 7.6 Southeast Asia Somatostatin Sales and Growth Rate (2014-2019) 8 South America Somatostatin by Country 8.1 South America Somatostatin Sales, Revenue and Market Share by Country 8.1.1 South America Somatostatin Sales and Market Share by Country (2014-2019) 8.1.2 South America Somatostatin Revenue and Market Share by Country (2014-2019) 8.2 Brazil Somatostatin Sales and Growth Rate (2014-2019) 8.3 Argentina Somatostatin Sales and Growth Rate (2014-2019) 8.4 Colombia Somatostatin Sales and Growth Rate (2014-2019) 9 Middle East and Africa Somatostatin by Countries 9.1 Middle East and Africa Somatostatin Sales, Revenue and Market Share by Country 9.1.1 Middle East and Africa Somatostatin Sales and Market Share by Country (2014-2019) 9.1.2 Middle East and Africa Somatostatin Revenue and Market Share by Country (2014-2019) 9.2 Saudi Arabia Somatostatin Sales and Growth Rate (2014-2019) 9.3 Turkey Somatostatin Sales and Growth Rate (2014-2019) 9.4 Egypt Somatostatin Sales and Growth Rate (2014-2019) 9.5 Nigeria Somatostatin Sales and Growth Rate (2014-2019) 9.6 South Africa Somatostatin Sales and Growth Rate (2014-2019) 10 Global Somatostatin Market Segment by Type 10.1 Global Somatostatin Sales, Revenue and Market Share by Type (2014-2019) 10.1.1 Global Somatostatin Sales and Market Share by Type (2014-2019) 10.1.2 Global Somatostatin Revenue and Market Share by Type (2014-2019) 10.2 0.25 Sales Growth and Price 10.2.1 Global 0.25 Sales Growth (2014-2019) 10.2.2 Global 0.25 Price (2014-2019) 10.3 0.75 Sales Growth and Price 10.3.1 Global 0.75 Sales Growth (2014-2019) 10.3.2 Global 0.75 Price (2014-2019) 10.4 3 Sales Growth and Price 10.4.1 Global 3 Sales Growth (2014-2019) 10.4.2 Global 3 Price (2014-2019) 11 Global Somatostatin Market Segment by Application 11.1 Global Somatostatin Sales Market Share by Application (2014-2019) 11.2 Application I Sales Growth (2014-2019) 11.3 Application II Sales Growth (2014-2019) 12 Somatostatin Market Forecast (2019-2024) 12.1 Global Somatostatin Sales, Revenue and Growth Rate (2019-2024) 12.2 Somatostatin Market Forecast by Regions (2019-2024) 12.2.1 North America Somatostatin Market Forecast (2019-2024) 12.2.2 Europe Somatostatin Market Forecast (2019-2024) 12.2.3 Asia-Pacific Somatostatin Market Forecast (2019-2024) 12.2.4 South America Somatostatin Market Forecast (2019-2024) 12.2.5 Middle East and Africa Somatostatin Market Forecast (2019-2024) 12.3 Somatostatin Market Forecast by Type (2019-2024) 12.3.1 Global Somatostatin Sales Forecast by Type (2019-2024) 12.3.2 Global Somatostatin Market Share Forecast by Type (2019-2024) 12.4 Somatostatin Market Forecast by Application (2019-2024) 12.4.1 Global Somatostatin Sales Forecast by Application (2019-2024) 12.4.2 Global Somatostatin Market Share Forecast by Application (2019-2024) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Future Trend 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source

Methodology

This research report involves complete picture of the market with the help of in-depth secondary and primary research. This research report studies several aspects of the market and analyze vital industry influencers. Extensive secondary research has been conducted using paid as well as open access data sources in order to gather information on the market and parent market. These key findings are then analyzed and validated with the help of in-house data models and primary discussions with key industry participants and experts across the value chain

research-methodology

Research Tools and Models

  • Top-Down Approach and Bottom-Up Approach
  • QFD Modeling for Market Size and Share Calculation
  • Regression, Variable and Impact Analysis
  • Penetration Modeling

Qualitative Research

  • It comprises briefing about market dynamics and business opportunities and strategies.
  • Finally, all the research findings are validated through interviews with in-house industry experts, freelance consultants and key opinion leaders etc.

Quantitative Research

It involves various mathematical tools, models, projection, and sampling techniques. It involves following steps:

  • Identification of market variables and market size derivation
  • Assessment of future prospects, opportunities and market penetration rates by analyzing product commercialization, regional trends etc.
  • Evaluation historical market trends and derivation of present and future year-on-year growth trends

Fill below details to get free sample !!

Contact Us
Call Now